ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 9, September 2026 | pp. 612–619
DOI: 10.46882/AJIDR/148994
Article Type: Research Article
Title: Molecular epidemiology and integrase strand transfer inhibitor resistance mutations in treatment-experienced HIV-1 patients
Names of Authors: Tendai Moyo¹*, Annika Lindholm², Rajesh Kulkarni³
Abstract: Integrase strand transfer inhibitors are widely deployed in first-line and second-line antiretroviral regimens, yet emerging resistance-associated mutations threaten long-term virological suppression. We evaluated HIV-1 subtype diversity and integrase resistance mutations among individuals experiencing virological failure on dolutegravir-based therapy. Plasma samples from 230 viremic patients underwent viral load quantification and Sanger sequencing of the pol integrase region. Major resistance mutations including R263K and G118R were identified in 6.5 percent of participants, predominantly within HIV-1 subtype C infections. Routine drug resistance surveillance is critical to preserve integrase inhibitor efficacy.
Keywords: HIV-1, Integrase inhibitors, Dolutegravir resistance, Antiretroviral therapy, Molecular epidemiology
Citation: Moyo T, Lindholm A, Kulkarni R (2026). Molecular epidemiology and integrase strand transfer inhibitor resistance mutations in treatment-experienced HIV-1 patients. African Journal of Infectious Diseases Research, 13(9): 612–619. DOI: 10.46882/AJIDR/148994
Manuscript Timeline: Received: July 18, 2026; Revised: August 16, 2026; Accepted: September 02, 2026; Published: September 08, 2026
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read